Each EU or EEA country where a clinical trial is intended to be conducted: When a clinical trial is planned in the EU, it must be submitted for approval within the CTIS under CTR and all member states where the trial is intended to be run in, are included in the review process that determines whether the conduct of the clinical trial is approved or not as “member states concerned”.
